Masiliūnienė Greta, Gumbrevičius Gintautas, Stankevičius Edgaras, Kaduševičius Edmundas
Institute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus 9, LT-44307 Kaunas, Lithuania.
Department of Adult Intensive Care and Resuscitation, Kaunas Hospital of the Lithuanian University of Health Sciences, Josvainių 2, LT-47144 Kaunas, Lithuania.
Healthcare (Basel). 2025 Jul 3;13(13):1592. doi: 10.3390/healthcare13131592.
: Previous studies have shown that a major part of adverse drug reactions (ADRs) are preventable, and they contribute to increased morbidity, mortality, and costs. To our knowledge, no study investigating preventable ADRs has been carried out in Lithuania. Therefore, the aim of this study was to characterize ADRs in the intensive care unit (ICU) of a secondary care Lithuanian hospital as well as to identify drug classes and organ systems most commonly implicated in preventable and nonpreventable ADRs. : This observational prospective study was conducted in an 18-bed ICU of Kaunas Hospital of the Lithuanian University of Health Sciences from 1 September 2021 to 31 August 2023. All ADRs were assessed for causality, severity, and preventability. The Anatomical Therapeutic and Chemical (ATC) system was used to classify drug classes implicated in ADRs. The organ systems affected were analyzed using the Medical Dictionary for Regulatory Activities (MedDRA). : A total of 154 patients with a median age of 78.8 years (range, 18-97) were enrolled into this study. There were 255 ADRs identified; preventable ADRs accounted for 87.5%. Among the preventable ADRs, the top three therapeutic subgroups were antithrombotic agents (26.5%), anti-inflammatory and antirheumatic products (22.0%), and blood substitutes and perfusion solutions (20.2%). Meanwhile, among nonpreventable ADRs, antibacterials for systemic use (62.5%) and antithrombotic agents (46.9%) were the two most common therapeutic subgroups. The gastrointestinal as well as the skin and subcutaneous tissues organ systems were more likely to be affected by nonpreventable ADRs (56.3% vs. 17.5%, ˂ 0.05 and 12.5% vs. 0.4%, ˂ 0.05, respectively), while the renal and urinary organ systems were more likely to be affected by preventable ADRs (38.1% vs. 6.3%, ˂ 0.05). : Our study showed a very high incidence of preventable ADRs (87.5%). Drugs affecting blood and blood-forming organs were most frequently implicated in these ADRs. This area deserves special attention and strategies need to be implemented to reduce the incidence of preventable ADRs and their impact on the healthcare system. Moreover, it emphasizes the need for future studies at a national level as, to our knowledge, this is the first study addressing the issues of avoidable harm at the ICU of one Lithuanian hospital.
以往研究表明,大部分药物不良反应(ADR)是可预防的,它们会导致发病率、死亡率上升以及成本增加。据我们所知,立陶宛尚未开展过关于可预防ADR的研究。因此,本研究的目的是描述立陶宛一家二级护理医院重症监护病房(ICU)中的ADR特征,并确定在可预防和不可预防的ADR中最常涉及的药物类别和器官系统。
本观察性前瞻性研究于2021年9月1日至2023年8月31日在立陶宛健康科学大学考纳斯医院的一个拥有18张床位的ICU中进行。对所有ADR进行因果关系、严重程度和可预防性评估。使用解剖学治疗学及化学分类系统(ATC)对涉及ADR的药物类别进行分类。使用《药物监管活动医学词典》(MedDRA)分析受影响的器官系统。
共有154名患者纳入本研究,中位年龄为78.8岁(范围18 - 97岁)。共识别出255例ADR;可预防的ADR占87.5%。在可预防的ADR中,前三大治疗亚组为抗血栓药物(26.5%)、抗炎和抗风湿产品(22.0%)以及血液代用品和灌注液(20.2%)。同时,在不可预防的ADR中,全身用抗菌药物(62.5%)和抗血栓药物(46.9%)是两个最常见的治疗亚组。胃肠道以及皮肤和皮下组织器官系统更易受到不可预防ADR的影响(分别为56.3%对17.5%,P < 0.05;12.5%对0.4%,P < 0.05),而肾脏和泌尿系统器官系统更易受到可预防ADR的影响(38.1%对6.3%,P < 0.05)。
我们的研究显示可预防ADR的发生率非常高(87.5%)。影响血液和造血器官的药物最常涉及这些ADR。这一领域值得特别关注,需要实施策略以降低可预防ADR的发生率及其对医疗保健系统的影响。此外,并强调有必要在国家层面开展未来研究,因为据我们所知,这是第一项解决立陶宛一家医院ICU中可避免伤害问题的研究。